Late-stage melanoma was once untreatable. Immunotherapy is changing that

Late-stage melanoma was once untreatable. Immunotherapy is changing that

Melanoma seems to have found its match in immunotherapy, a type of treatment designed to help the immune system fight cancer. Just a decade ago, only one-in-20 patients would live for five years after being diagnosed with late-stage melanoma, with most dying in months. But drugs designed to trigger the body’s immune system mean 52 percent of patients now live for at least five years, according to a new clinical trial.

Patients with melanoma, which is the fifth most common cancer in the UK, can be cured if the cancer is caught in its early stages, but as cancer spreads throughout the body, then survival plummets. With immunotherapy, however, researchers have found that tumors are reduced in size and stunted from growing any bigger.

Are these patients cured? Saying cured is always difficult in cancer, but five-year-survival is a hugely significant milestone. Some patients taking the drugs…
Continue Reading at The Optimist Daily…

JOIN OUR PREMIUM MEMBERSHIP TODAY

By becoming a premium member, you'll have full access to all content and be supporting the Warp News non-profit foundation and our efforts to spread fact-based optimism all over the world.

You've successfully subscribed to Warp News
Great! Next, complete checkout for full access to Warp News
Welcome back! You've successfully signed in.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info is updated.
Billing info update failed.